Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters

Database
Language
Affiliation country
Publication year range
1.
J Pharm Pharmacol ; 64(5): 644-53, 2012 May.
Article in English | MEDLINE | ID: mdl-22471360

ABSTRACT

OBJECTIVES: Zinc is a useful addition to oral rehydration therapy for acute diarrhoea. We have assessed the mechanism of its epithelial antisecretory action when intestinal epithelial tight junctions were pharmacologically opened. METHODS: Rat isolated ileal and colonic mucosae were mounted in Ussing chambers and exposed to ZnSO(4) (Zn(2+) ) in the presence of secretagogues and inhibition of short circuit current (I(sc) ) was measured. KEY FINDINGS: Pre-incubation with basolateral but not apical Zn(2+) reduced I(sc) stimulated by forskolin, carbachol and A23187. In the presence of the tight junction-opener, cytochalasin D, antisecretory effects of apically-applied Zn(2+) were enabled in colon and ileum. The apparent permeability coefficient (P(app) ) of Zn(2+) was increased 1.4- and 2.4-fold across rat ileum and colon, respectively, by cytochalasin D. Basolateral addition of Zn(2+) also reduced the I(sc) stimulated by nystatin in rat colon, confirming K channel inhibition. In comparison with other inhibitors, Zn(2+) was a relatively weak blocker of basolateral K(ATP) and K (Ca2+) channels. Exposure of ileum and colon to Zn(2+) for 60 min had minimal effects on epithelial histology. CONCLUSIONS: Antisecretory effects of Zn(2+) on intestinal epithelia arose in part through nonselective blockade of basolateral K channels, which was enabled when tight junctions were open.


Subject(s)
Diarrhea/drug therapy , Intestinal Mucosa/drug effects , Intestinal Secretions/drug effects , Ions/metabolism , Potassium Channels/drug effects , Tight Junctions/physiology , Zinc/pharmacology , Animals , Antidiarrheals/pharmacology , Antidiarrheals/therapeutic use , Calcimycin/pharmacology , Carbachol/pharmacology , Colforsin/pharmacology , Colon/drug effects , Cytochalasin D/pharmacology , Diarrhea/physiopathology , Electricity , Ileum/drug effects , Intestinal Mucosa/physiopathology , Intestinal Secretions/physiology , Ionophores/pharmacology , Male , Nystatin/pharmacology , Permeability , Potassium Channel Blockers/pharmacology , Potassium Channels/physiology , Rats , Rats, Wistar , Tight Junctions/drug effects , Zinc/therapeutic use , Zinc Sulfate/pharmacology
2.
Eur J Pharmacol ; 696(1-3): 166-71, 2012 Dec 05.
Article in English | MEDLINE | ID: mdl-23022335

ABSTRACT

Zinc's usefulness in the treatment of diarrhoea is well established as an addition to oral rehydration. Mechanisms of action of zinc have been explored in intestinal epithelia from rodents and in cell lines. The aim was to examine how zinc alters ion transport and signal transduction in human colon in vitro. Voltage clamped colonic sheets obtained at the time of surgical resection were used to quantify ion transport responses to established secretagogues. Nystatin permeabilisation was used to study basolaterally-sited ion channels. Direct actions of zinc were determined using preparations of colonic crypts isolated from human mucosal sheets. Electrophysiological measurements revealed zinc to be an inhibitor of electrogenic ion transport stimulated by forskolin, PGE(2), histamine and carbachol in isolated human colonic epithelium. Basolateral addition of zinc sulphate had no direct effect on the epithelium. To further outline the mechanism of action, levels of secondary intracellular messengers (3', 5'-cyclic adenosine monophosphate; cAMP) were determined in isolated colonic crypts, and were found to be reduced by zinc sulphate. Finally, indirect evidence from nystatin-permeabilised mucosae further suggested that zinc inhibits basolateral K(+) channels, which are critical for transepithelial Cl(-) secretion linked to water flux. Anti-secretory, and therefore anti-diarrhoeal, actions of exogenous zinc are due, at least in part, to direct basolateral epithelial K(+) channel inhibition.


Subject(s)
Chlorides/metabolism , Colon/drug effects , Intestinal Mucosa/drug effects , Zinc Sulfate/pharmacology , Adult , Aged , Aged, 80 and over , Colon/metabolism , Female , Humans , In Vitro Techniques , Intestinal Mucosa/metabolism , Male , Middle Aged
3.
Eur J Pharm Sci ; 38(4): 291-300, 2009 Nov 05.
Article in English | MEDLINE | ID: mdl-19737613

ABSTRACT

The effects of two absorption promoters, (sodium caprate (C(10)) and melittin), on intestinal permeability and viability were measured in intact rat and human colonic epithelia mounted in Ussing chambers. Apical-side addition of C(10) (10 mM) and melittin (10-50 microM) rapidly reduced the transepithelial electrical resistance (TEER) and increased the apparent permeability coefficient (Papp) of [(14)C]-mannitol and FITC-dextran-4 kDa (FD4) across colonic mucosae from both species. Effects of C(10) on flux were greater than those of melittin at the concentrations selected. C(10) irreversibly decreased TEER, but the effects of melittin were partially reversible. Enhanced permeability of polar sugars (0.18-70 kDa) in colonic mucosae with C(10) was accompanied by significant release of lactate dehydrogenase (LDH) from the luminal surface as well as by inhibition of electrogenic chloride secretion induced by the muscarinic agonist, carbachol (0.1-10 microM). Although melittin did not alter electrogenic chloride secretion in rat or human colonic mucosae, it caused leakage of LDH from rat tissue. Gross histology and electron microscopy of rat and human colonic mucosae demonstrated that each permeation enhancer can induce colonic epithelial damage at concentrations required to increase marker fluxes. C(10) led to more significant mucosal damage than melittin, characterised by sloughing and mucosal erosion. Overall, these results indicate that while C(10) and melittin increase transport of paracellular flux markers across isolated human and rat colonic mucosae in vitro, these effects are associated with some cytotoxicity.


Subject(s)
Colon/metabolism , Decanoic Acids/toxicity , Intestinal Absorption/drug effects , Intestinal Mucosa/drug effects , Intestinal Mucosa/metabolism , Melitten/toxicity , Animals , Caco-2 Cells , Colon/drug effects , Colon/enzymology , Decanoic Acids/metabolism , Humans , In Vitro Techniques , Intestinal Absorption/physiology , Intestinal Mucosa/enzymology , L-Lactate Dehydrogenase/metabolism , Male , Melitten/metabolism , Permeability/drug effects , Rats , Rats, Wistar
SELECTION OF CITATIONS
SEARCH DETAIL